SAFETY AND EFFICACY OF BIO-101 175MG B.I.D AND 350 MG B.I.D. 26-WEEK ORAL ADMINISTRATION TO PATIENTS SUFFERING FROM AGE-RELATED SARCOPENIA, INCLUDING SARCOPENIC OBESITY, AGED 65 YEARS AND AT RISK OF MOBILITY DISABILITY. A DOUBLE-BLIND, PLACEBO CONTROLLED
Principal Investigator(s)
Musi, Nicolas
Funded by
BIOPHYTIS
Research Start Date
Status
Active